# What's new in DF14 endpoints

The changes in DF14 endpoints are listed below.

* **New WIDE version endpoints created (Primary health care codes \[Avohilmo] added)**
  * 95 infectious disease endpoints (naming: AB1\_XXX\_WIDE)
  * H7\_CONJUNCTIVITISACUNONATOPIC\_WIDE
  * H7\_EYELIDINFLAMMATION\_WIDE
  * H8\_NONSUPPNAS\_WIDE
  * L12\_ACNE\_WIDE
* **New WIDE version endpoints created (additional codes added)**
  * AUTOHEP\_WIDE
* **New WIDE versions cancer endpoints created (Hospital inpatient codes \[Hilmo] added)**
  * C3\_BONE\_CARTILAGE\_WIDE
  * C3\_COLORECTAL\_WIDE
  * C3\_DIGESTIVE\_ORGANS\_WIDE
  * C3\_ENDOCRINE\_WIDE
  * C3\_EYE\_BRAIN\_NEURO\_WIDE
  * C3\_FEMALE\_GENITAL\_WIDE
  * C3\_HEAD\_AND\_NECK\_WIDE
  * C3\_MALE\_GENITAL\_WIDE
  * C3\_MESTOTHEL\_SOFTTISSUE\_WIDE
  * C3\_RESPIRATORY\_INTRATHORACIC\_WIDE
  * C3\_SKIN\_WIDE
  * C3\_URINARY\_TRACT\_WIDE
  * C3\_LIQUID\_CANCER\_WIDE
  * C3\_SOLID\_CANCER\_WIDE
* **New phenotypes created**
  * Primary Sclerosing Cholangitis, IBD and UDCA required (K11\_PSC)
  * Benign thyroid growths and nodules (THYGROWTHS)
  * Primary biliary cholangitis, wide definition (K11\_PBC\_WIDE)
  * Urinary track infection (N14\_UTI\_FEMALE\_WIDE)
  * Malignant neoplasm (C3\_SOLID\_LIQUID\_CANCER)
  * Malignant neoplasm, including Hilmo (C3\_SOLID\_LIQUID\_CANCER\_WIDE)
* **Endpoint definition corrected:**
  * M13\_SLE
  * Q17\_PDA
  * N14\_UTER\_POLYP
  * PACEMAKER
  * C3\_MELANOMA
  * C3\_MELANOMA\_WIDE
  * INFLUENCA
  * C3\_LIVER\_INTRAHEPATIC\_BILE\_DUCTS
  * C3\_LIVER\_INTRAHEPATIC\_BILE\_DUCTS\_WIDE
  * LUNG\_CANCER\_MESOT
  * K11\_KELAIBD
  * RHEUMA\_SEROPOS\_WIDE
  * E4\_THYROID
  * MYELOPROF
  * C3\_KIDNEY\_NOTRENALPELVIS\_WIDE
  * C3\_LIQUID\_CANCER
  * C3\_CANCER
  * C3\_CANCER\_WIDE
  * C3\_SOLID\_CANCER
* **Renamed endpoints (definitions not changed)**
  * M13\_OVERLAP renamed as M13\_MCTD
  * H7\_OPTATROPHY renamed as H7\_OPTATROPHY\_WIDE
  * AB1\_DIBTHERIA renamed as AB1\_DIPTHERIA
  * AB1\_DIBTHERIA\_WIDE renamed as AB1\_DIPTHERIA\_WIDE
  * C3\_EPENDYDOMA renamed as C3\_EPENDYMOMA
  * N14\_UTER\_POLYP renamed as N14\_CERVIC\_POLYP
  * CD2\_FOLLICULAR\_LYMPHOMA renamed as C3\_FOLLICULAR\_LYMPHOMA
  * CD2\_HODGKIN\_LYMPHOMA renamed as C3\_HODGKIN\_LYMPHOMA
  * CD2\_IMMUNOPROLIFERATIVE renamed as C3\_IMMUNOPROLIFERATIVE
  * CD2\_INDEPENDENT\_MULTIPLE\_SITES renamed as C3\_INDEPENDENT\_MULTIPLE\_SITES
  * CD2\_INDEPENDENT\_MULTIPLE\_SITES\_NAS renamed as C3\_INDEPENDENT\_MULTIPLE\_SITES\_NAS
  * CD2\_LEUKAEMIA\_NAS renamed as C3\_LEUKAEMIA\_NAS
  * CD2\_LYMPHOID\_LEUKAEMIA renamed as C3\_LYMPHOID\_LEUKAEMIA
  * CD2\_MONOCYTIC\_LEUKAEMIA renamed as C3\_MONOCYTIC\_LEUKAEMIA
  * CD2\_MULTIPLE\_MYELOMA\_PLASMA\_CELL renamed as C3\_MULTIPLE\_MYELOMA\_PLASMA\_CELL
  * CD2\_MYELOID\_LEUKAEMIA renamed as C3\_MYELOID\_LEUKAEMIA
  * CD2\_NEOPLASM renamed as C3\_NEOPLASM
  * CD2\_NONFOLLICULAR\_LYMPHOMA renamed as
  * CD2\_NONHODGKIN\_NAS renamed as C3\_NONHODGKIN\_NAS
  * CD2\_OTHER\_LEUKAEMIA\_SPECIFIED renamed as C3\_OTHER\_LEUKAEMIA\_SPECIFIED
  * CD2\_OTHER\_SPECIAL\_TNK\_LYMPHOMA renamed as C3\_OTHER\_SPECIAL\_TNK\_LYMPHOMA
  * CD2\_PRIMARY\_LYMPHOID\_HEMATOPOIETIC renamed as C3\_PRIMARY\_LYMPHOID\_HEMATOPOIETIC
  * CD2\_PRIMARY\_LYMPHOID\_HEMATOPOIETIC\_NAS renamed as C3\_PRIMARY\_LYMPHOID\_HEMATOPOIETIC\_NAS
  * CD2\_TNK\_LYMPHOMA renamed as C3\_TNK\_LYMPHOMA
  * CD2\_UVEAMELANOMA renamed as C3\_UVEAMELANOMA
* **Core endpoint status updated (WILL be part of the R14 core GWAS analyses)**
  * C3\_ASTROCYTOMA
  * C3\_BASAL\_CELL\_CARCINOMA
  * C3\_BREAST\_HER2NEG\_WIDE
  * C3\_BURKITT\_WIDE
  * C3\_HEART\_MEDIASTINUM\_PLEURA\_WIDE
  * C3\_TONSIL\_WIDE
* **Core endpoint status updated (WON’T be part of the R14 core GWAS analyses)**
  * AB1\_DERMATOPHYTOSIS
  * AB1\_ERYSIPELAS
  * AB1\_HERPES\_SIMPLEX
  * AB1\_VIRAL\_SKIN\_NOS
  * AB1\_ZOSTER
  * C3\_BURKITT
  * C3\_CIRCULATING\_LYMPHOID
  * C3\_DIGESTIVE\_ORGANS
  * C3\_ENDOCRINE
  * C3\_EYE\_BRAIN\_NEURO
  * C3\_FEMALE\_GENITAL
  * C3\_HEAD\_AND\_NECK
  * C3\_MALE\_GENITAL
  * C3\_MEDULLOBLASTOMA
  * C3\_MESTOTHEL\_SOFTTISSUE
  * C3\_OVARY\_MUCINO
  * C3\_OVARY\_SEROUS
  * C3\_RESPIRATORY\_INTRATHORACIC
  * C3\_SKIN
  * C3\_SQUAMOUS\_CELL\_CARCINOMA\_SKIN
  * C3\_TONSIL
  * C3\_URINARY\_TRACT
  * C3\_SOLID\_CANCER
  * C3\_LIQUID\_CANCER
  * C3\_WILMS\_TUMOR
  * AB1\_SCARLET\_FEVER\_WIDE
  * AB1\_VIRAL\_OTHER\_INTEST\_INFECTIONS\_WIDE
* **New tags added**
  * CD2 tag added to 22 endpoints
  * C3 tag added to 8 endpoints
  * INSITU tag added 64 endpoints


---

# Agent Instructions: Querying This Documentation

If you need additional information that is not directly available in this page, you can query the documentation dynamically by asking a question.

Perform an HTTP GET request on the current page URL with the `ask` query parameter:

```
GET https://docs.finngen.fi/finngen-data-specifics/endpoints/where-the-finngen-endpoint-description-file-is-located/whats-new-in-df14-endpoints.md?ask=<question>
```

The question should be specific, self-contained, and written in natural language.
The response will contain a direct answer to the question and relevant excerpts and sources from the documentation.

Use this mechanism when the answer is not explicitly present in the current page, you need clarification or additional context, or you want to retrieve related documentation sections.